In the Media

Montreal-based Licensed Producer Cannara Biotech began with a bang in early 2018. By July of that year, they had secured a 625,000-square-foot facility in southern Quebec.

A retrospective on the cannabis market after 5 years of legalization.
Extremely positive article about Cannara Biotech Inc. in the French Canadian newspaper “La Presse”.

4/20 special series with Nicholas on insights on the cannabis industry’s developments and prospects.

Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company’s success in the cannabis industry. Sosiak discussed the company’s strategic acquisitions, including the purchase of a 1 million square foot cannabis facility for $27 million, significantly below its initial cost. Cannara Biotech Inc. has also developed three in-house brands: Tribal, Nugs, and Orchid CBD, each catering to specific market niches. The company places a strong emphasis on consistency and quality to drive brand loyalty among consumers.

With the demand for high-quality, affordably priced cannabis growing in Canada, Cannara Biotech Inc.’s (LOVFF) investments seem to be paying off. The vertically integrated producer of premium-grade cannabis and derivative product offerings has used investment dollars to produce quality cannabis products and increase the number of growing zones. That has resulted in Montreal-based Cannara Biotech reporting record-setting revenue for its first quarter and forecast even more growth to come in 2024.

Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc., LOVFF, the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.

A retrospective on the cannabis market after 5 years of legalization.

“Le Soleil”, a 1896 Quebec-based paper, brings us an amazing article glorifying Cannara’s success. Interesting quotes from key organization players including the CFO, the CEO, the CTO and the General Manager.

PODCAST: Hosted by Alex, the founder/owner of Weedcrawler and BestBangforYourBud.
Extremely interesting podcast. Cannara helped Weedcrawler start up and they have helped us tremendously about market data over the years.

PODCAST: Hosts Charlie and Sean Kady are excited to welcome entrepreneur and chartered professional accountant Nicholas Sosiak, also known as Niko Dank, to the show.

Cannara announced its upcoming participation at Canaccord Genuity’s 7th annual global cannabis conference.

Video Interview with our CFO Nick Sosiak.

Nick Sosiak, or Niko Dank, CFO and Senior Product Developer at Cannara Biotech, shares an in-depth look at the Quebec limited partnership’s operations and its role in forming three brands backed by the art of cannabis breeding .

TMX is a Canadian company that provides customized information and workflow solutions to clients in the financial and energy industries. Their services include real-time market data, analytics, and trading solutions.

Our CFO shares his expertise on the crucial topic of sustainability and its immense benefits within the booming cannabis industry.

Video Conference with Nick & Sequire Events

Listen to the full podcast on Spotify. Nick elaborates on the Cannara Brand as a whole and touches on a multitude of subjects.

Interview with The Wall Street Analyzer & Nick Sosiak

Our CFO, Nicholas Sosiak, has ranked #6 of the top 25 Healthcare Technology Leaders from Montreal.

In this podcast from the “Disciplined Stoners”, Nicholas Sosiak & KIND organizer Nicole Wolfe discuss the KIND Winter Fair event.

Our CFO, Nicholas Sosiak talks about the KIND Winter Fair that happened in Toronto’s “Rendez-View” on the 7th & 8th of December 2022. Live from CityTV!

In this article from the Cannabis Growing Magazine “Grow Opportunity“, Nicholas Sosiak discusses the various aspects of strategic partnerships between LPs and people who breed Cannabis.

In this episode, Nick Morin interviews Nicholas Sosiak from Cannara BioTech, we get to learn about the Canadian cannabis industry, his vision to grow great cannabis and more!

During the show, Nicholas details his journey into the cannabis industry, how Cannara came to be, his love of genetics, the joys and challenges of the Canadian cannabis industry, and what’s next for Cannara.

Technical420 goes deep in financial analysis of Cannara

You will be getting an update on Cannara’s recent financials and plans for the next few quarters, new products and partnerships, and much more!

Read about why Cannara is one of the most misunderstood cannabis operators in North America.

Well-established Quebec cultivator enters into exclusive brand partnership with Exotic Genetix.

Discussion with journalist Emile Berube-Lupien on Canada’s place in the recent legislation.

Nicholas Sosiak joins OTCQB to share how the company crafts the brand and culture to build brand loyalty.

Nicholas takes us through his journey as CFO for Cannara Biotech as he shares insights into the critical success factors that any cannabis entrepreneur should fully grasp.

Interview with The Green Peak discussing Cannara’s growth strategy and the viability of growing/cultivation in Canada.

Listen as they explore the unique Quebec market, Cannara’s business model, why flower remains king and how his team is building immense brand loyalty despite stringent marketing regulations.

Topics Discussed:

The current state of the second wave of Canadian LPs
Shifting focus from cultivation to CPG
Product formulation trends in Canada
Canadian cannabis marketing restrictions
Genetics to keep SKUs fresh and maintain sales volume

The piece highlights Q1 earnings, Cannara’s footprint in Quebec and how flower continues to steer the sales in the cannabis market.

“The market might be shifting to a “second wave” of cannabis cultivators who focus more on the craft side of growing than the large companies that control the bulk of the market.” said Nick Sosiak, Chief Financial Officer.

Our CFO discusses the accelerated retail price compression of cannabis products.

Discussion about the new Valleyfield facility, market outlook, MD&A, regulations, financials and much more.